ABSTRACT
To investigate the outcomes of macrosomia and compare the risk factors associated with neonatal and maternal complications between mothers with gestational diabetes [GDM] and Non-GDM mothers, and determine whether it is important to screen for GDM before birth. We sampled the venous blood of the mothers of 120 macrosomic neonates in the first 24 hours after delivery, and assessed glycohemoglobin [HbA1c] levels. A diagnosis of GDM was based on a HbA1c > 5.9%. Twenty-three [19%] mothers had an HgbA1c > 5.9%. Maternal and neonatal complications were not significantly different in undiagnosed GDM and non-GDM women. Except for the mother's age, parity, and BMI, other risk factors for the development of GDM didn't differ significantly between the two groups. The frequency of neonatal and maternal complications associated with the birth of macrosomic neonates are not significantly different between GDM and non-GDM mothers. Hence, the universal screening of pregnant women for GDM is not recommended